NEW YORK (GenomeWeb News) – Queens University in Belfast said today it will lead a €6 million ($8.3 million) international project that seeks to investigate genes that make bowel cancer so deadly and hard to treat.

Funded by the European Commission's Seventh Framework Programme, the MErCuRIC project will focus on genes that may be involved in a particularly aggressive type of colorectal cancer that affects around 50 percent of CRC patients, and which has a five-year survival rate of less than five percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.